[Comment] β-lactam prolonged infusion: it's time to implement!

In the Lancet Infectious Diseases, Konstantinos Z Vardakas and colleagues1 show that prolonged (extended or continuous) infusion of antipseudomonal β-lactams reduced mortality compared with intermittent dosing in a systematic review of randomised controlled trials (RCTs).

Source: The Lancet Infectious Diseases - October 25, 2017 Category: Infectious Diseases Authors: Mical Paul, Ursula Theuretzbacher Tags: Comment Source Type: research